Anthony Christiano
Greenville, NCNPI 1326040775
Payments from drug & device makers
Across 208 payments — averaging $10.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$468
- Amgen$418
- Johnson & Johnson$253
- AstraZeneca$197
- United Therapeutics Corporation$168
- Stryker$153
- plus $622 from 12 others
What the payments were for
- Food & beverage$2,11393%
- Education$1677%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 86 | $468 |
| Amgen | 31 | $418 |
| Johnson & Johnson | 37 | $253 |
| AstraZeneca | 13 | $197 |
| United Therapeutics Corporation | 3 | $168 |
| Stryker | 1 | $153 |
| GE HealthCare | 1 | $148 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $113 |
| Philips North America LLC | 7 | $105 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Pfizer | 3 | $39 |
| Novartis | 3 | $37 |
| Chiesi USA, Inc. | 2 | $34 |
| Boston Scientific | 2 | $30 |
| Lundbeck LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Abiomed | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GAMMA$153
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.